Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Statin Treatment in Multiple Sclerosis: A Systematic Review and Meta-Analysis.
Astrocyte loss and astrogliosis in neuroinflammatory disorders.
Treatment with interferon-beta does not induce anti-nuclear and anti-neuronal serum autoantibodies in multiple sclerosis patients.
Alemtuzumab treatment of multiple sclerosis.
Interleukin-10 expression during the acute phase is a putative prerequisite for delayed viral elimination in a murine model for multiple sclerosis.
MUltiple Sclerosis and Extract of Cannabis: results of the MUSEC trial.
Histone deacetylase activity is required for human oligodendrocyte progenitor differentiation.
New EMA Advice to Reduce PML Risk With Natalizumab (Tysabri) in MS
Transvascular autonomic modulation: a modified balloon angioplasty technique for the treatment of autonomic dysfunction in multiple sclerosis patients.
Long-Term Effectiveness and Safety of Nabiximols (Tetrahydrocannabinol/Cannabidiol Oromucosal Spray) in Clinical Practice.
Characterisation of uveitis in association with multiple sclerosis.
Progression of multiple sclerosis is associated with gender differences in glutathione S-transferase P1 detoxification pathway.
Safety and efficacy of fingolimod in clinical practice: The experience of an academic center in the Middle East.
Characterization of Oligodendroglial Populations in Mouse Demyelinating Disease Using Flow Cytometry: Clues for MS Pathogenesis.
Where is the causal variant? On the advantage of the family design over the case-control design in genetic association studies.
BREMSO: a simple score to predict early the natural course of multiple sclerosis.
PLZF Regulates CCR6 and Is Critical for the Acquisition and Maintenance of the Th17 Phenotype in Human Cells.
MicroRNA regulation of lymphocyte tolerance and autoimmunity.
An unusual case of recurrent Guillain-Barré syndrome with normal cerebrospinal fluid protein levels: a case report.
Obstetrical epidural and spinal anesthesia in multiple sclerosis.
Rituximab, B-lymphocyte depletion, and preservation of beta-cell function.
Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica.
N-methyl-D-aspartate (NMDA) receptor involvement in central nervous system prostaglandin production during the relapse phase of chronic relapsing experimental autoimmune encephalomyelitis (CR EAE).
[Olfactory dysfonction in multiple sclerosis: role for subventricular zone progenitors].
No additional copies of HERV-Fc1 in the germ line of multiple sclerosis patients.
Pages
« first
‹ previous
…
274
275
276
277
278
279
280
281
282
…
next ›
last »